Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$654M |
| 2 |
State Street SPDR S&P Global Natural Resources ETF
GNR
|
+$241M |
| 3 |
iShares Gold Trust
IAU
|
+$232M |
| 4 |
VanEck Oil Services ETF
OIH
|
+$200M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$165M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$852M |
| 2 |
Microsoft
MSFT
|
+$575M |
| 3 |
Carvana
CVNA
|
+$540M |
| 4 |
Target
TGT
|
+$430M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$376M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.49% |
| 2 | Financials | 5.96% |
| 3 | Consumer Discretionary | 5.3% |
| 4 | Healthcare | 4.99% |
| 5 | Communication Services | 3.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
C4 Therapeutics
CCCC
$385M
| $578K | ﹤0.01% |
23,818
-58,658
| -71% | -$1.42M |
|
3352
Global E Online
GLBE
$6.6B
| $578K | ﹤0.01% |
17,116
-2,032
| -11% | -$76.7K |
|
3353
Wendy's
WEN
$1.4B
| $577K | ﹤0.01% |
26,257
+6,073
| +30% | +$137K |
|
3354
Gossamer Bio
GOSS
$82.9M
| $576K | ﹤0.01% |
66,409
-86,376
| -57% | -$833K |
|
|
CDAQ
3355
DELISTED
Compass Digital Acquisition Corp. Class A Ordinary Shares
CDAQ
| $576K | ﹤0.01% |
+59,762
| New | +$576K |
|
|
NP
3356
DELISTED
Neenah, Inc. Common Stock
NP
| $576K | ﹤0.01% |
14,532
+1,589
| +12% | +$68K |
|
3357
Radian Group
RDN
$5.18B
| $573K | ﹤0.01% |
25,769
-45,846
| -64% | -$1.05M |
|
3358
Invesco S&P 500 Top 50 ETF
XLG
$10.6B
| $573K | ﹤0.01% |
16,310
+710
| +5% | +$24.4K |
|
|
PPL
3359
CALL
PPL Corp
PPL
$26.5B
| $571K | ﹤0.01% |
20,000
-25,000
| -56% | -$705K |
|
3360
Inogen
INGN
$175M
| $570K | ﹤0.01% |
17,571
-3,825
| -18% | -$120K |
|
|
AL
3361
DELISTED
Air Lease Corp
AL
| $567K | ﹤0.01% |
12,703
-131,368
| -91% | -$5.5M |
|
3362
BioLife Solutions
BLFS
$1.53B
| $567K | ﹤0.01% |
24,924
+6,937
| +39% | +$183K |
|
3363
National Vision
EYE
$1.77B
| $567K | ﹤0.01% |
13,008
-27,337
| -68% | -$1.11M |
|
3364
UMB Financial
UMBF
$11.1B
| $567K | ﹤0.01% |
5,841
-9,610
| -62% | -$981K |
|
3365
MannKind Corp
MNKD
$1.21B
| $564K | ﹤0.01% |
153,075
-518,140
| -77% | -$1.89M |
|
|
SWTX
3366
CALL
DELISTED
SpringWorks Therapeutics
SWTX
| $564K | ﹤0.01% |
+10,000
| New | +$572K |
|
|
DGNU
3367
DELISTED
Dragoneer Growth Opportunities Corp. III Class A Ordinary Shares
DGNU
| $563K | ﹤0.01% |
57,661
| – | – |
|
3368
iShares MSCI Sweden ETF
EWD
$546M
| $562K | ﹤0.01% |
14,472
-6,314
| -30% | -$257K |
|
3369
Prudential
PUK
$37.6B
| $562K | ﹤0.01% |
18,973
-16,899
| -47% | -$540K |
|
3370
SiriusPoint
SPNT
$2.75B
| $562K | ﹤0.01% |
75,072
+8,010
| +12% | +$63.3K |
|
|
SRRA
3371
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $561K | ﹤0.01% |
17,490
+10,146
| +138% | +$291K |
|
3372
Herbalife
HLF
$1.29B
| $559K | ﹤0.01% |
18,413
+1,503
| +9% | +$58.8K |
|
3373
OraSure Technologies
OSUR
$279M
| $559K | ﹤0.01% |
82,512
+7,103
| +9% | +$56.7K |
|
|
ALTR
3374
DELISTED
Altair Engineering Inc
ALTR
| $558K | ﹤0.01% |
8,676
-9,768
| -53% | -$616K |
|
3375
Kyndryl
KD
$2.99B
| $556K | ﹤0.01% |
42,354
-18,522
| -30% | -$279K |
|
Similar funds
Citigroup's Q1 2022 Portfolio in Review
As of Q1 2022, Citigroup held 6,926 positions worth $165B, down 12% from $187B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Citigroup withdrew a net $11.2B in Q1 2022, closing 497 positions and reducing 3,025 holdings. Its most notable exit was Xilinx Inc, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Citigroup opened a new position in ProShares UltraPro Short QQQ worth $126M.
- Citigroup's largest Q1 2022 buy was ProShares UltraPro Short QQQ: 149,740 shares worth $126M.
- Citigroup added most to iShares Russell 2000 ETF in Q1 2022, an estimated $654M increase.
- Citigroup's biggest Q1 2022 reduction was Apple, cutting an estimated $852M.
- Citigroup fully exited Xilinx Inc in Q1 2022, selling an estimated $235M.
- Citigroup's ten largest holdings make up 28% of its $165B portfolio in Q1 2022.
- Citigroup opened 1,006 new positions and closed 497 in Q1 2022.
- Citigroup's portfolio value fell 12% quarter-over-quarter to $165B.
Based on Citigroup's 13F filing for Q1 2022, filed 12 May 2022.